SEQIRUS INC
FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICAL TRIAL IMPLEMENTATION
View on USAspending.gov → · Award 75A50126F61015 · Delivery Order
4 awards in the U.S. signed in the last 90 days, worth $45.0M in total. Every item links to the official record.
| Recipient | Awards | Total |
|---|---|---|
| SEQIRUS INC | 2 | $44.9M |
| LAMPIRE BIOLOGICAL LABS INC | 1 | $34,870 |
| LONZA WALKERSVILLE, INC | 1 | $30,645 |
Top recipients by total obligated amount for this filter. D&B-restricted records are left out.
FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICAL TRIAL IMPLEMENTATION
View on USAspending.gov → · Award 75A50126F61015 · Delivery Order
EO 14398: ANIMAL WHOLE BLOOD FOR BLOOD COMPATIBILITY TESTING
View on USAspending.gov → · Award 75F40126P00297 · Purchase Order
NIEHS: THIS ACQUISITION WILL PROVIDE 60 VIALS OF SPHEROID-QUALIFIED HUMAN LIVER CELLS FROM 30 MALE AND 30 FEMALE DONORS TO SUPPORT NCATS/NIEHS COMPLEMENT-ARIE RESEARCH FOCUSED ON DEVELOPING 3D MICROPHYSIOLOGICAL SYSTEMS FOR MODELING CHEMIC…
View on USAspending.gov → · Award 75N98026P01800 · Purchase Order
MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)
View on USAspending.gov → · Award 75A50126F61014 · Delivery Order
Also as JSON. USAspending publishes Defense awards about 90 days after signing.